Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose

NCT00673790 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT00673790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00673790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood Pressure and Metabolic Effects of Nebivolol Compared With Hydrochlorothiazide and Placebo in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
Lead sponsor
Forest Laboratories
Phase
Phase 4
Overall status
Completed
Start date
May 15, 2008
Completion date
July 9, 2010
Enrollment
537 (actual)
Sites
88

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension